ALVO
Alvotech Sa - Joel Morales Steps Down as CFO of Alvotech
时间:2025-07-10 16:40:00 市场: 美股 综合
Alvotech Appoints Linda JÓNsdÓTtir as Chief Financial Officer
时间:2025-07-10 16:40:00 市场: 美股 综合
Alvotech Expands Its Capacity in Assembly and Packaging With the Acquisition of Ivers-Lee in Switzerland
时间:2025-07-09 16:29:59 市场: 美股 综合
Alvotech and Advanz Pharma Enter Into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (Certolizumab Pegol)
时间:2025-07-01 16:00:00 市场: 美股 综合
Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility
时间:2025-06-26 16:15:00 市场: 综合 美股
Teva: Process to Obtain Regulatory Approval Is Anticipated to Be Completed in Q4 of 2025
时间:2025-02-18 19:00:04 市场: 综合 美股
Alvotech Sa - FDA Accepts for Review Bla for Alvotech's Biosimilar to Eylea
时间:2025-02-18 19:00:01 市场: 综合 美股
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for Avt06, a Proposed Biosimilar to Eylea® (Aflibercept)
时间:2025-02-18 19:00:01 市场: 美股 综合
Alvotech Sa - Regulatory Approval Expected by Q4 2025
时间:2025-02-18 19:00:01 市场: 美股 综合
Alvotech Sa - FDA Review Process Expected to Complete in Q4 2025
时间:2025-01-27 19:00:01 市场: 美股 综合